Key Statistics for QIA
|Current P/E Ratio (ttm)
Relative P/E vs.
|Earnings Per Share (USD) (ttm)
|Est. EPS (USD) (12/2013)
|Est. PEG Ratio
|Market Cap (M EUR)
|Shares Outstanding (M)
|30 Day Average Volume
|Dividend Indicated Gross Yield
|5 Year Dividend Growth
|Next Earnings Announcement
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for QIA
- Net Income (M/USD)
QIAGEN N.V. provides sample and assay technologies. The Company's technologies (in the format of consumables and automated solutions) are used to process biological samples and to analyze analytes contained therein, such as DNA and RNA. QIAGEN provides these technologies to customers conducting molecular diagnostics, applied testing, pharmaceutical R&D and academic research.
More Company Profile & Key Executives for QIA
|Peer M SchatzCEO/Managing Director||Roland SackersCFO/Managing Director|
|Tadd S LazarusChief Medical Officer||Bernd UderSenior VP:Global Sales/Mng Dir|
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries